The latest Fact.MR study indicates healthcare facilities, contract research organizations, and educational & research institutes collectively spent ~US$ 1,950 Mn on eCOA, eSource and clinical trials solutions in 2018. The eCOA, eSource & clinical trials market is envisaged to witness substantial traction through 2019, with gains primarily driven by the growing penetration of digitization in healthcare sector and substantial increase in pharma spending on clinical trials.
Rapidly expanding deployment of clinical trial solutions, which contributed to ~40% of the total spending on eCOA, eSource, and clinical trials in 2018, will continue to appeal a widening bandwidth of institutions through 2029, says the report.
Competitive Assessment
The eCOA, eSource & clinical trials market report includes global as well as emerging players:
- OpenClinica, LLC
- CRF Health, Inc.
- ERT Clinical
- Medidata Solutions, Inc.
- ArisGlobal LLC
- Health Diary, Inc.
- ICON plc
- PAREXEL International Corporation
- OmniComm Systems, Inc
- PAREXEL International Corporation
- Medrio, Inc.
- PAREXEL International Corporation
- Medable
The insights for each vendor consists of:
- Company profile
- SWOT analysis
- Main market information
- Market share
- Revenue, pricing and gross margin
Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4042
Regional Analysis
Important regions covered in the eCOA, eSource & clinical trials market report include:
- North America
- Latin America
- Europe
- Middle East and Africa
- East Asia
- South Asia
- Oceania
Spending on eCOA Set to Quadruple
The Fact.MR study opines that though the deployment of clinical trial solutions overshadowed the use of Electronic Clinical Outcome Assessment (eCOA), eSource, and EDA in 2018, the market is envisaged to witness a range of changes during the foreseeable period. Growing penetration of Bring Your Own Device (BYOD) trend in clinical trials is highly likely to pace up the use of eCOAs, such as ePROS, ClinROs, ObsROs, and PerfORs across wide range of pharmaceutical companies and research facilities.
eCOAs is envisaged to hold ~45% of the overall spending share by the end of 2029, in line with the growing use of smartphones and tablets to seamlessly collect clinical data for analysis. Additionally, reduced cost and high scalability of eCOA are the primary determinants that continue to push its adoption during clinical trials, which is envisaged to contribute significantly to the growth of the eCOA, eSource & clinical trials market.
The eCOA, eSource & clinical trials market report also provides data regarding the key countries in the defined regions.
Segmentation Analysis
By Solution Type:
- ePROs (Patient Reported Outcomes)
- ClinROs (Clinician Reported Outcomes)
- ObsROs (Observer reported Outcomes)
- PerfOs (Performance Outcomes)
- eSource
- Clinical Data Management Systems (CDMS)
- Clinical Trial Management Systems (CTMS)
- Randomization and Trial Supply Management Systems (RTMS)
- Trail Planning and Safety Solutions
- Electronic Data Capture (EDC)
By end user:
- Contract Research Organizations
- Hospitals & Other Healthcare Facilities
- Pharmaceutical/Biotechnology/Medical Devices Companies
- Educational & Research Institutes
What insights does the eCOA, eSource & clinical trials market report provide to the readers?
- ECOA, eSource & clinical trials market fragmentation on the basis of product type, end use, and region.
- Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
- Collaborations, R&D projects, acquisitions, and product launches of each eCOA, eSource & clinical trials market player.
- Various regulations imposed by the governments on the consumption of eCOA, eSource & clinical trials market in detail.
- Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global eCOA, eSource & clinical trials market.
Stakeholders Eyeing Opportunities through Collaborations
As the healthcare sector delves deeper into advanced technology, a large number of companies have formulated unique strategies to remain unaffected by the curve of change. Several pharmaceutical companies, research organizations and CROs have placed their focus on collaborations, while they embrace digitization to create patient-centric experiences. For instance, Signant Health has launched a partner program to collaborate with Clinical Research Organizations (CROs) that are dedicated towards improving clinical trials using patient-centric technology.
Additionally, Iqvia has recently launched a novel eCOA cloud based technology platform to quantify the patient experience, while increasing efficiency and reducing timelines at the same time.
Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=4042
Growing Demand for Clinical Trials to Underpin Spending of Emerging Regions
As per the Fact.MR study, the increasing prevalence of various chronic infectious diseases has led to a dire unmet need for efficient clinical trials in developing countries. Moreover the rising medical expense in these regions, which can be attributed to the fact that private hospitals are the key healthcare providers herein, continue to fuel clinical trial participation in developing countries. This, coupled with the growing awareness about the cost and efficiency benefits of using eCOA, eSource & clinical trial solutions for conducting clinic trials, and comparatively lenient regulatory framework are likely to add to the lucrativeness of developing countries, such as China and India for market players.
Questionnaire answered in the eCOA, eSource & clinical trials market report include:
- How the market for eCOA, eSource & clinical trials market has grown over the historic period of 2014-2018?
- What is the present and future outlook of the global eCOA, eSource & clinical trials market on the basis of region?
- What are the challenges and opportunities for the eCOA, eSource & clinical trials market?
- Why the consumption of eCOA, eSource & clinical trials market highest in region?
- In which year segment is expected to overtake segment?
The latest Fact.MR study indicates healthcare facilities, contract research organizations, and educational & research institutes collectively spent ~US$ 1,950 Mn on eCOA, eSource and clinical trials solutions in 2018.
The eCOA, eSource & clinical trials market is envisaged to witness substantial traction through 2019, with gains primarily driven by the growing penetration of digitization in healthcare sector and substantial increase in pharma spending on clinical trials.Rapidly expanding deployment of clinical trial solutions, which contributed to ~40% of the total spending on eCOA, eSource, and clinical trials in 2018, will continue to appeal a widening bandwidth of institutions through 2029, and says the report.Spending on eCOA Set to Quadruple The Fact.MR study opines that though the deployment of clinical trial solutions overshadowed the use of Electronic Clinical Outcome Assessment (eCOA), eSource, and EDA in 2018, the market is envisaged to witness a range of changes during the foreseeable period.
Growing penetration of Bring Your Own Device (BYOD) trend in clinical trials is highly likely to pace up the use of eCOAs, such as ePROS, ClinROs, ObsROs, and PerfORs across wide range of pharmaceutical companies and research facilities.eCOAs is envisaged to hold ~45% of the overall spending share by the end of 2029, in line with the growing use of smartphones and tablets to seamlessly collect clinical data for analysis.
Additionally, reduced cost and high scalability of eCOA are the primary determinants that continue to push its adoption during clinical trials, which is envisaged to contribute significantly to the growth of the eCOA, eSource & clinical trials market.You can Request an Example Copy from here - https://www.factmr.com/connectus/sample?flag=S_id=4042Stakeholders Eyeing Opportunities through CollaborationsAs the healthcare sector delves deeper into advanced technology, a large number of companies have formulated unique strategies to remain unaffected by the curve of change.
Several pharmaceutical companies, research organizations and CROs have placed their focus on collaborations, while they embrace digitization to create patient-centric experiences.
For instance, Signant Health has launched a partner program to collaborate with Clinical Research Organizations (CROs) that are dedicated towards improving clinical trials using patient-centric technology.
Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global eCOA, eSource & Clinical Trials market during the historical period of 2014 – 2018.
The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2029, and key prospects over the forecast period 2019 – 2029.Rapidly expanding deployment of clinical trial solutions, which contributed to ~40% of the total spending on eCOA, eSource, and clinical trials in 2018, will continue to appeal a widening bandwidth of institutions through 2029, says the report.
Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the eCOA, eSource & Clinical Trials market, both at global and regional levels.
The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the eCOA, eSource & Clinical Trials market.Request to View Sample of Report @ https://www.factmr.com/connectus/sample?flag=S_id=4042After reading the eCOA, eSource & Clinical Trials market report, readers get insight into:Major drivers and restraining factors, opportunities and challenges, and the competitive landscapeNew, promising avenues in key regionsNew revenue streams for all players in emerging marketsFocus and changing role of various regulatory agencies in bolstering new opportunities in various regionsDemand and uptake patterns in key industries of the eCOA, eSource & Clinical Trials marketNew research and development projects in new technologies in key regional marketsChanging revenue share and size of key product segments during the forecast periodTechnologies and business models with disruptive potentialThe eCOA, eSource & Clinical Trials market report offers assessment of prevailing opportunities in various regions and evaluates their shares of revenue by the end of different years of the assessment period.
Key regions covered comprise:North AmericaLatin AmericaEuropeEast AsiaSouth Asia & OceaniaMiddle East & AfricaThe evaluation of the competitive landscape in the eCOA, eSource & Clinical Trials market covers the profile of the following top players: PAREXEL International CorporationBio-Optronics, Inc.PAREXEL International CorporationPAREXEL International CorporationThe global eCOA, eSource & Clinical Trials market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period.
In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.
